Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (42)
  • Antibacterial
    (29)
  • Endogenous Metabolite
    (14)
  • Antibiotic
    (12)
  • STAT
    (10)
  • Antifungal
    (8)
  • Akt
    (7)
  • CDK
    (7)
  • Autophagy
    (6)
  • Others
    (215)
Filter
Search Result
Results for "

survival

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    377
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    8
    TargetMol | Compound_Libraries
  • Peptide Products
    29
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    17
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    4
    TargetMol | Dye_Reagents
  • PROTAC Products
    6
    TargetMol | PROTAC
  • Natural Products
    46
    TargetMol | Natural_Products
  • Reagent Kits
    5
    TargetMol | Reagent_Kits
  • Recombinant Protein
    196
    TargetMol | Recombinant_Protein
  • Isotope Products
    5
    TargetMol | Isotope_Products
  • Antibody Products
    2
    TargetMol | Antibody_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
  • Cell Research
    3
    TargetMol | Inhibitors_Agonists
VTP50469
T133362169916-18-9
VTP50469 is a highly selective and orally active small molecule inhibitor of the Menin-MLL protein-protein interaction with potent anti-leukemic activity with a Ki of 104 pM.
  • $176
In Stock
Size
QTY
TargetMol | Inhibitor Hot
PND-1186
VS-4718, SR-2516, PND1186, PND 1186
T19501061353-68-1
PND-1186 (VS-4718) is a specific and reversible FAK inhibitor with an IC50 of 1.5 nM.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
RA-9
T8464919091-63-7
RA-9 is a potent and selective proteasome-associated inhibitor of deubiquitinating enzymes (DUBs) with a favorable toxicity profile and anticancer activity, particularly effective in inducing apoptosis in ovarian cancer cell lines.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale
MAC-545496
T8507838810-96-1
MAC-545496 is a glycopeptide-resistance-associated protein R (GraR) inhibitor, is an antivirulence agent.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
BRD0705
T106062056261-41-5
BRD0705 is a potent, orally active GSK3α inhibitor with high selectivity (IC50: 66 nM; Kd: 4.8 μM), demonstrating an 8-fold higher selectivity for GSK3α compared to GSK3β (IC50: 515 nM).
  • $91
In Stock
Size
QTY
CGP60474
T14943164658-13-3
CGP60474 is an inhibitor of VEGFR-2 (IC50 = 84 nM) and an inhibitor of ATP-competitive PKC. CGP60474 is also a highly potent anti-endotoxemic agent and inhibits cyclin-dependent kinase (CDK) potently.
  • $30
In Stock
Size
QTY
Iobenguane sulfate
MIBG sulfate
T1558887862-25-7
Iobenguane sulfate (MIBG sulfate) is a high-affinity substrate for cholera toxin that disrupts cellular mono(ADP-ribosylation). Radioiodinated Iobenguane sulfate is used clinically as a tumor-targeted radiopharmaceutical for diagnosing and treating adrenergic tumors.
  • $64
In Stock
Size
QTY
Fanotaprim
T366922120282-75-7
Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor, suppressing the growth of T. gondii strains with a TgDHFR IC50 of 1.57 ± 0.11 nM, a hDHFR IC50 of 308 ± 71 nM, and a hDHFR to TgDHFR selectivity ratio of 196.
  • $48
In Stock
Size
QTY
PF-3758309 hydrochloride
PF-03758309 hydrochloride
T42301279034-84-2
PF-3758309 hydrochloride (PF-03758309 hydrochloride) , is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PF-3758309 hydrochloride binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival.
  • $37
In Stock
Size
QTY
Branaplam
NVS-SM1, LMI 070
T46411562338-42-4
Branaplam (LMI 070) is a highly potent, selective and orally active small molecule SMN2 splicing modulator.
  • $42
In Stock
Size
QTY
MGCD-265 analog
T6351875337-44-3
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
  • $30
In Stock
Size
QTY
Vactosertib
TEW-7197, EW-7197
T64961352608-82-2
Vactosertib (EW-7197) is an orally bioavailable inhibitor of the serine/threonine kinase, transforming growth factor (TGF)-beta receptor type 1 (TGFBR1), also known as activin receptor-like kinase 5 (ALK5), with potential antineoplastic activity.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
PF-3758309
PF-309, PF-03758309, PF 3758309
T6626898044-15-0
PF-3758309 (PF-03758309) (IC50=1.3 nM), a pyrrolopyrazole inhibitor of PAK4, has effective ATP-competition.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Mepolizumab
SB 240563
T9962196078-29-2
Mepolizumab (SB 240563) is a humanized monoclonal antibody that neutralizes IL-5, and can be utilized in research on severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
  • $163
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Risdiplam
RO7034067, RG7916
T167571825352-65-5
Risdiplam (RG7916) is a centrally and peripherally distributed and orally administrable small molecule SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Ibrutinib
PCI-32765
T1835936563-96-1
Ibrutinib (PCI-32765) is an irreversible inhibitor of BTK (IC50: 0.5 nM) that selectively blocks B cell activation.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
NNK
Nicotine-derived nitrosamine ketone
T2053364091-91-4
NNK is a nitrosated derivative of nicotine that activates the ERK1/2 and PKCα signaling pathways, induces Bcl2 phosphorylation at Ser70, and activates c-Myc at Thr58 and Ser62, thereby promoting the proliferation and survival of human lung cancer cells, and is commonly used to establish lung cancer mouse models.
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
TRC051384
TRC 051384
T3527867164-40-7
TRC051384 is a heat shock protein 70 (HSP70) inducer that reduces stroke-associated neuronal damage and increases survival in a rat model of transient ischemic stroke, activates heat shock factor-1 and leads to elevated molecular chaperone and anti-inflammatory activity, and enhances Hsp72 expression in neurons and glial cells.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
NF-κΒ activator 1
T399652387524-59-4
NF-κΒ activator 1 can activate the nf-kappa Β gene activator, EC50 of 0.9 microns. NF-κΒ is widely used in eukaryotic cells as a gene regulating cell proliferation and cell survival. NF-κΒ activator 1 induces superoxide dismutase (SOD) 2 1 mRNA expression.
  • $87
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Ginkgetin
T4S2126481-46-9
1. Ginkgetin has anti-influenza virus and anti-fungal activities. 2. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses. 3. Ginkgetin is a good STAT3 inhibitor and may be a useful lead
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Adhesamine
T73094462605-73-8
Adhesamine, a dumbbell-shaped molecule, plays a crucial role in activating the MAPK/FAK pathway, thus promoting mammalian cell adhesion and growth. Additionally, it accelerates the differentiation and enhances the survival of mice hippocampal neurons in primary culture.
  • $1,520
6-8 weeks
Size
QTY
TargetMol | Inhibitor Hot
OT-82
OT82, OT 82
T123301800487-55-1In house
OT-82 is a potent, selective, and orally active inhibitor of nicotinamide phosphoribosyltransferase (NAMPT).
  • $147
In Stock
Size
QTY
Abiraterone metabolite 1
3β-OH-5α-Abi
T135251940176-03-3In house
Abiraterone Metabolite 1, a 5β-reduced derivative of abiraterone, acts by inhibiting CYP17A1, thereby blocking androgen synthesis and extending survival in prostate cancer patients.
  • $1,520
6-8 weeks
Size
QTY
Tulopafant
RP 59227
T17178116289-53-3In house
Tulopafant (RP 59227) is a potent platelet-activating factor (PAF) antagonist that increases capillary patency and prolongs allograft heart survival.
  • $700
In Stock
Size
QTY